Dystonia
-
Subject Areas on Research
- A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.
- A Role for Dystonia-Associated Genes in Spinal GABAergic Interneuron Circuitry.
- A novel presentation of DYT 16: acute onset in infancy and association with MRI abnormalities.
- Abnormal cerebellar signaling induces dystonia in mice.
- Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
- Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study.
- Comparison of Deep Brain Stimulation Lead Targeting Accuracy and Procedure Duration between 1.5- and 3-Tesla Interventional Magnetic Resonance Imaging Systems: An Initial 12-Month Experience.
- DYT-TOR1A subcellular proteomics reveals selective vulnerability of the nuclear proteome to cell stress.
- Deep Brain Stimulation for Pediatric Dystonia.
- Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration.
- Defining research priorities in dystonia.
- Drug-induced dystonia in neuronal ceroid-lipofuscinosis.
- Dysphagia in the setting of left ventricular assist device hemolysis.
- Dystonia as a side effect of nonneuroleptics.
- Dystonia with and without deafness is caused by TIMM8A mutation.
- Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.
- Evaluation and treatment of dystonia.
- Experimental dystonia induced by quaternary-chlorpromazine.
- Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia.
- Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration.
- Laryngeal dystonia causing inspiratory stridor in children with cerebral palsy.
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
- Mouse model of rare TOR1A variant found in sporadic focal dystonia impairs domains affected in DYT1 dystonia patients and animal models.
- Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome.
- Safety considerations for deep brain stimulation: review and analysis.
- The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.
- Torticollis acquired in late infancy due to a cerebellar gangliocytoma.
- Tourettism and dystonia after subcortical stroke.
- Treatment of diaphragmatic dystonia with pallidal deep brain stimulation.
-
Keywords of People
- Bukhari-Parlakturk, Noreen, Assistant Professor of Neurology, Duke Institute for Brain Sciences
- Calakos, Nicole, Lincoln Financial Group Distinguished Professor of Neurobiology, Duke Science & Society
- Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
- Turner, Dennis Alan, Professor of Neurosurgery, Biomedical Engineering